Who owns Atyr Pharma Inc?
- Ticker: ATYR
- CUSIP Number: 002120202
Tip: Access positions for across all investors
Analyze quarterly positions in Atyr Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv

Top investors of Atyr Pharma stock
Who bought or sold Atyr Pharma Inc this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Federated Investors | 15M | $44M | 0% | Mar 2025 |
|
FMR | 13M | $39M | 7% | Mar 2025 |
|
Vanguard Group | 4.0M | $12M | 11% | Mar 2025 |
|
Octagon Capital Advisors | 3.6M | $11M | 295% | Mar 2025 |
|
Point72 Asset Management | 2.8M | $8.6M | -42% | Mar 2025 |
|
Tikvah Management | 2.5M | $8.9M | 0% | Dec 2024 |
|
Woodline Partners | 1.7M | $6.1M | 0% | Dec 2024 |
|
UBS Group | 1.6M | $4.9M | 613% | Mar 2025 |
|
Millennium Management | 1.6M | $4.8M | 335% | Mar 2025 |
|
BlackRock | 1.6M | $4.8M | 5% | Mar 2025 |
|
Alyeska Investment Group | 1.3M | $3.9M | 0% | Mar 2025 |
|
Logos Global Management | 1.0M | $3.6M | -50% | Dec 2024 |
|
Geode Capital Management | 928k | $2.8M | 4% | Mar 2025 |
|
Susquehanna International | 822k | $3.0M | 456% | Dec 2024 |
|
Ally Bridge Group | 700k | $2.5M | 100% | Dec 2024 |
|
Tang Capital Management | 671k | $2.0M | 0% | Mar 2025 |
|
MAI Wealth Advisors | 658k | $2.0M | 306100% | Mar 2025 |
|
Erste Asset Management GmbH | 600k | $1.8M | 100% | Mar 2025 |
|
Renaissance Technologies | 480k | $1.4M | -16% | Mar 2025 |
|
Qube Research & Technologies | 430k | $1.6M | 209% | Dec 2024 |
|
Citadel Advisors | 395k | $1.2M | 603% | Mar 2025 |
|
Goldman Sachs Group | 382k | $1.2M | 46% | Mar 2025 |
|
Integral Health Asset Management | 375k | $1.4M | 100% | Dec 2024 |
|
State Street Corporation | 367k | $1.1M | 22% | Mar 2025 |
|
GSA Capital Partners | 332k | $1.0M | 21% | Mar 2025 |
|
Jane Street | 255k | $770k | 28% | Mar 2025 |
|
683 Capital Management | 248k | $898k | 100% | Dec 2024 |
|
Dimensional Fund Advisors | 243k | $881k | 67% | Dec 2024 |
|
Barclays | 237k | $715k | 49% | Mar 2025 |
|
Balyasny Asset Management | 227k | $686k | 413% | Mar 2025 |
|
Knott David M Jr | 223k | $675k | -27% | Mar 2025 |
|
Northern Trust | 187k | $564k | 2% | Mar 2025 |
|
Dauntless Investment Group | 171k | $516k | 100% | Mar 2025 |
|
Wellington Management Company | 169k | $510k | 100% | Mar 2025 |
|
Wells Fargo & Company | 168k | $508k | 59% | Mar 2025 |
|
OMERS Administration Corporation | 148k | $447k | 7% | Mar 2025 |
|
Main Street Financial Solutions | 134k | $405k | 100% | Mar 2025 |
|
Simplex Trading | 97k | $292k | 636% | Mar 2025 |
|
Bank of America Corporation | 91k | $330k | 14614% | Dec 2024 |
|
Jain Global | 88k | $266k | 100% | Mar 2025 |
|
Schonfeld Strategic Advisors | 64k | $230k | -84% | Dec 2024 |
|
Leucadia National Corporation | 56k | $168k | 0% | Mar 2025 |
|
Brevan Howard Capital Management | 53k | $161k | 100% | Mar 2025 |
|
Alliancebernstein | 52k | $157k | 100% | Mar 2025 |
|
Cannon Global Investment Management | 48k | $144k | 100% | Mar 2025 |
|
Verition Fund Management | 46k | $137k | 100% | Mar 2025 |
|
Morgan Stanley | 41k | $149k | 100% | Dec 2024 |
|
D.A. Davidson & Co. | 40k | $121k | 3% | Mar 2025 |
|
Charles Schwab Investment Management | 40k | $121k | 1% | Mar 2025 |
|
Kingswood Wealth Advisors | 37k | $110k | -21% | Mar 2025 |
|
Tower Research Capital | 33k | $119k | 143% | Dec 2024 |
|
Wolverine Trading | 32k | $113k | 100% | Dec 2024 |
|
J. Goldman & Co | 30k | $91k | -90% | Mar 2025 |
|
Diametric Capital | 30k | $108k | 100% | Dec 2024 |
|
Squarepoint Ops | 27k | $96k | 99% | Dec 2024 |
|
Royal Bank of Canada | 25k | $75k | -90% | Mar 2025 |
|
Farther Finance Advisors | 24k | $70k | 0% | Mar 2025 |
|
Apollon Wealth Management | 24k | $71k | 100% | Mar 2025 |
|
American Century Companies | 23k | $69k | -74% | Mar 2025 |
|
Two Sigma Investments | 22k | $67k | 3% | Mar 2025 |
|
Springbok Capital Management | 21k | $64k | 112% | Mar 2025 |
|
XTX Topco | 20k | $59k | 75% | Mar 2025 |
|
Capstone Investment Advisors | 18k | $56k | 100% | Mar 2025 |
|
Catalyst Funds Management Pty | 18k | $54k | 100% | Mar 2025 |
|
Alpine Partners VI | 17k | $63k | 100% | Dec 2024 |
|
ExodusPoint Capital Management | 17k | $61k | 100% | Dec 2024 |
|
Man Group | 15k | $55k | 100% | Dec 2024 |
|
Boothbay Fund Management | 15k | $53k | 100% | Dec 2024 |
|
Raymond James Financial | 14k | $42k | 30% | Mar 2025 |
|
United Bank | 14k | $42k | 100% | Mar 2025 |
|
Hudson Bay Capital Management | 13k | $40k | 100% | Mar 2025 |
|
Y-Intercept | 13k | $38k | 100% | Mar 2025 |
|
Actinver Wealth Management | 10k | $30k | 0% | Mar 2025 |
|
Group One Trading | 7.2k | $26k | 100% | Dec 2024 |
|
Point72 Asia | 1.3k | $3.8k | 2% | Mar 2025 |
|
Sachetta | 830.00 | $2.5k | 108% | Mar 2025 |
|
Nbc Securities | 700.00 | $2.0k | 100% | Mar 2025 |
|
PFS Partners | 340.00 | $1.0k | 0% | Mar 2025 |
|
Continuum Advisory | 210.00 | $633.990000 | 0% | Mar 2025 |
|
Caldwell Sutter Capital | 52.00 | $156.998400 | 0% | Mar 2025 |
|
Strategic Investment Solutions | 8.00 | $24.000000 | 0% | Mar 2025 |
|
Citigroup | 1.00 | $3.000000 | -100% | Mar 2025 |
|
Who sold out of Atyr Pharma?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Adage Capital Partners GP | Dec 2024 | 1.0M | $3.6M |
Checkpoint Capital | Dec 2024 | 433k | $1.6M |
Stempoint Capital | Dec 2024 | 201k | $726k |
Jpmorgan Chase & Co | Dec 2024 | 179k | $646k |
Oxford Asset Management | Dec 2024 | 32k | $115k |
Engineers Gate Manager | Sep 2024 | 16k | $28k |
Marshall Wace | Sep 2024 | 14k | $25k |
Two Sigma Securities | Sep 2024 | 13k | $23k |
Ground Swell Capital | Sep 2024 | 13k | $22k |
Two Sigma Advisers | Dec 2024 | 12k | $44k |
Victory Capital Management | Dec 2024 | 10k | $37k |
BFSG | Dec 2024 | 2.0k | $7.2k |
National Bank Of Canada /fi/ | Dec 2024 | 358.00 | $1.3k |
Bnp Paribas Arbitrage, Snc | Dec 2024 | 2.00 | $7.000000 |